Primary Record
D-Valsartan
- In stock
- 926 g
- Purity
- 99.7 %
- CAS
- 137862-87-4
Compound Identifiers & Properties
- CAS
- 137862-87-4
- PubChem CID
- 5284633
- SMILES
- CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)[C@H](C(C)C)C(=O)O
- Canonical SMILES
- CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1)[C@@H](C(=O)O)C(C)C
Names & Synonyms
- D-Valsartan
- valsartan
- ent-Valsartan
- Valsartan, D-
- 137862-87-4
- (R)-Valsartan
- R-Valsartan
- Valsartan EP impurity A
- Valsartan related compound A
- Valsartan Impurity A
- Valsartan, D-impurity
- UNII-IDC67444MI
- (R)-2-(N-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutanoic acid
- AC1NR4SZ
- RefChem:203432
- IDC67444MI
- CGP-49309
- SCHEMBL2328
- CHEMBL115622
- MFCD18252868
- Valsartan related compound A [USP]
- Valsartan specified impurity A
- Valsartan specified impurity A [EP]
- DTXCID603735
- DTXSID6023735
- SCHEMBL24722321
- SCHEMBL29518879
- CTK8B5685
- Valsartan related compound A RS [USP]
- ACWBQPMHZXGDFX-JOCHJYFZSA-N
- Valsartan USP Related Compound A
- C24H29N5O3
- HY-I1208
- ZINC3831602
- Tox21_111447
- Valsartan related compound A (USP)
- ANW-49605
- BDBM50282371
- EBC-12897
- SC1407
- D-VALSARTAN (REFERENCE GRADE)
- AKOS015854410
- AKOS026751459
- VALSARTAN IMPURITY A [EP IMPURITY]
- ACN-026591
- CB11820
- CID5284633
- CS-O-08393
- IO22697
- Valsartan related compound A RS (USP)
- NCGC00095139-01
- BR-39369
- SY102423
- VALSARTAN RELATED COMPOUND A [USP-RS]
- VALSARTAN IMPURITY A (EP IMPURITY)
- AB0068858
- DB-322073
- J788.652G
- TR-005022
- CAS-137862-53-4
- CS-0011419
- ST24026402
- VALSARTAN RELATED COMPOUND A (USP-RS)
- VALSARTAN RELATED COMPOUND A [USP IMPURITY]
- S-7514
- (2R)-3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid
- A886383
- D-Valine, N-(1-oxopentyl)-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-
- EN300-18528142
- VALSARTAN RELATED COMPOUND A (USP IMPURITY)
- (2R)-3-Methyl-2-(pentanoyl((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)amino)butanoic acid
- D-Valine, N-(1-oxopentyl)-N-((2'-(2H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-
- Q27280672
- (R)-2-[N-[[2'-(5-Tetrazolyl)-4-biphenylyl]methyl]pentanamido]-3-methylbutanoic Acid
- B2694-264345
- (2R)-3-METHYL-2-(N-{[2'-(1H-1,2,3,4-TETRAZOL-5-YL)-[1,1'-BIPHENYL]-4-YL]METHYL}PENTANAMIDO)BUTANOIC ACID
- (2R)-3-methyl-2-[N-({4-[2-(1H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)pentanamido]butanoic acid
- (2R)-3-methyl-2-[pentanoyl-[[4-[2-(1H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid
- (R)-N-Valeryl-N-([2'-(1H-tetrazole-5-yl)-biphenyl-4-yl]-Methyl)-valine
- [(R-N-valeryl-N-([2'-(1H-tetrazole-5-yl)biphen-4-yl]methyl)valine)
- 137862-53-4
- N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-D-valine
- N-Valeryl-N-[[2 -(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-D-valine
- ((R)-N-Valeryl-N-([2'-(1H-tetrazole-5-yl)-biphenyl-4-yl]-methyl)-valine)
- (2R)-N-Valeryl-N-[2 -(1H-tetrazole-5-yl)biphenyl-4-ylmethyl]-2-isopropylglycine
- (R)-[N-VALERYL-N-([2'-(1H-TETRAZOLE-5-YL)BIPHEN-4-YL]METHYL)VALINE)
- N-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-N-pentanoyl-D-valine
- N-(1-Oxopentyl)-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-D-valine
- Valsartan Related Compound A, United States Pharmacopeia (USP) Reference Standard
- (2R)-3-Methyl-2-[pentanoyl[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]amino]butanoic Acid (Valsartan (R)-Enantiomer)
- (R)-2-(N-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutanoicacid
- (r)-2-(n-((2-(1h-tetrazol-5-yl)-[1,1-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutanoic acid
- (R)-3-Methyl-2-{pentanoyl-[2''-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric acid
- N-VALERYL-N-{[2'-(1HTETRAZOLE-5-YL)-BIPHENYL-4-YL]-METHYL}-D-VALINE(ent-Valsartan)(Valsartan Related Compound A), Pharmaceutical Secondary Standard; Certified Reference Material
- val
- Valsartan Imp. A (EP); Valsartan USP Related Compound A; Valsartan USP RC A; (2R)-3-Methyl-2-[pentanoyl[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]amino]butanoic Acid; CGP 49309, D-Valsartan, N-(1-oxopentyl)-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-D-Valine, Valsartan Related Compound A (USP), Valsartan Imp A (EP); Valsartan Related Compound A; Valsartan Impurity A